Autism, guidelines for an integrated approach

Journal title PNEI REVIEW
Author/s Francesco Bottaccioli, Anna Giulia Bottaccioli
Publishing Year 2017 Issue 2017/1 Language Italian
Pages 11 P. 6-16 File size 1085 KB
DOI 10.3280/PNEI2017-001002
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

In recent years, there has been a strong research development on aspects of the pathogenesis of autism which are closely interconnected: the role of the immune system of mother and child and consequently of infl ammation; stress during pregnancy and in the early stages of life; oxidative stress and related mitochondrial dysfunction; the disrupting action of environmental chemistry. This new knowledge about the pathogenesis of the disorder can guide the therapist not to remain trapped in its medical specialization (child neuropsychiatry) and to see the whole. In this framework the article describes the scientifi c evidence available about the use of different preventive and therapeutic tools of nutritional, relational, and cognitive type.

Keywords: Pathogenesis new knowledge, stress pregnancy, maternal immunity, infant immunity, integrated care

  1. American Psychiatric Association (2014) Manuale diagnostico e statistico dei disturbi mentali. 5th ed, Raffaello Cortina Editore, Milano, pp. 57-58, trad. it. di 2013, Diagnostic and statistical manual of mental disorders. 5th ed, Arlington, VA.
  2. Cheng W, Rolls ET, Gu H, et al. (2015) Autism: reduced connectivity between cortical areas involved in face expression, theory of mind, and the sense of self, Brain 138 (Pt 5):1382-1393. doi.org/10.1093/brain/awv051
  3. Hull JV, Jacokes ZJ, Torgerson CM, et al. (2016) Resting-State Functional Connectivity in Autism Spectrum Disorders: A Review, Front Psychiatry 7:205. doi.org/10.3389/fpsyt.2016.00205
  4. Estes ML e McAllister AK (2015) Immune mediators in the brain and peripheral tissues in autism spectrum disorder, Nat Rev Neurosci 16(8):469-486. doi.org/10.1038/nrn3978
  5. Estes A, Munson J, Rogers SJ, et al. (2015) Long-term outcomes of early intervention in 6-year-old children with autism spectrum disorder, J Am Acad Child Adolesc Psychiatry 54(7):580-587. doi.org/10.1016/j.jaac.2015.04.005
  6. Fulton E, Eapen V, Crnčec R, et al. (2014) Reducing maladaptive behaviors in preschool-aged children with autism spectrum disorder using the Early Start Denver Model, Front Pediatr 2:40. doi.org/10.3389/fped.2014.00040
  7. Gore AC (2015) Prenatal programming and endocrinology, Endocrinol 156(10):3403-3404. doi.org/10.1210/en.2015-1671
  8. Gregory SG, Anthopolos R, Osgood CE, et al. (2013) Association of autism with induced or augmented childbirth in North Carolina Birth Record (1990-1998) and Education Research (1997-2007) databases, JAMA Pediatr 167(10):959-966. doi.org/10.1001/jamapediatrics.2013.2904
  9. Guastella AJ e Hickie IB (2016) Oxytocin treatment, circuitry, and autism: a critical review of the literature placing oxytocin into the autism context, Biol Psychiatry 79(3):234-242. doi.org/10.1016/j.biopsych.2015.06.028
  10. Hansen SN, Schendel DE e Parner ET (2015) Explaining the increase in the prevalence of autism spectrum disorders: the proportion attributable to changes in reporting practices, JAMA Pediatr 69(1):56-62. doi.org/10.1001/jamapediatrics.2014.1893.
  11. Jia F, Wang B, Shan L, et al. (2015) Core Symptoms of Autism improved after vitamin D Supplementation, Pediatrics 135(1):e196-198. doi.org/10.1542/peds.2014-2121.
  12. Leyva-López N, Gutierrez-Grijalva EP, Ambriz-Perez DL, et al. (2016) Flavonoids as cytokine modulators: a possible therapy for infl ammation-related diseases, Int J Mol Sci 17(6):921. doi.org/10.3390/ijms17060921
  13. Li Q e Zhou JM (2016) The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder, Neuroscience 324:131-139. doi.org/10.1016/j.neuroscience.2016.03.013
  14. MacFabe DF (2015) Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders, Microb Ecol Health Dis 26:28177. doi.org/10.3402/mehd.v26.28177
  15. Niehus R e Lord C (2006) Early medical history of children with autism spectrum disorders, J Dev Behav Pediatr 27:S120-127. doi.org/10.1097/00004703-200604002-00010
  16. Shelton JF, Geraghty EM, Tancredi DJ, et al. (2014) Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: the CHARGE Study, Environ Health Perspect 122(10):1103-1109. doi.org/10.1289/ehp.1307044
  17. Taliou A, Zintzaras E, Lykouras L, et al. (2013) An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders, ClinTher 35(5):592-602. doi.org/10.1016/j.clinthera.2013.04.006
  18. Theoharides TC, Stewart JM, Panagiotidou S, et al. (2015) Mast cells, brain infl ammation and autism, Eur J Pharmacol 5(778):96. doi.org/10.1016/j.ejphar.2015.03.086

Francesco Bottaccioli, Anna Giulia Bottaccioli, L’autismo, linee per un approccio integrato in "PNEI REVIEW" 1/2017, pp 6-16, DOI: 10.3280/PNEI2017-001002